Selecting Outcome Measures for Veterinary Pain Studies

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Key Takeaways

• Construct Validity is Paramount: The primary challenge is distinguishing between nociception (neural processing of noxious stimuli) and pain (the subjective experience), as physiological measures (e.g., heart rate, cortisol) often reflect stress or nociception rather than pain perception itself. Behavioral and functional measures are generally considered closer proxies to the pain experience.
• Multidimensionality Requires Comprehensive Measurement: Pain is a multidimensional experience (sensory, affective, cognitive), necessitating the use of outcome measure sets that capture various domains, including behavioral observation scales, physiological parameters, functional assessments (e.g., gait analysis, activity monitoring), and owner-reported outcomes, especially for chronic pain.
• Species-Specific Validation is Critical: Outcome measures must be rigorously validated in the target species and context; cross-species extrapolation is a common and significant error that compromises study validity. Measures must also be feasible within the specific production system or clinical setting constraints.
• Reliability and Responsiveness are Essential for Detecting Effects: Measures must demonstrate high reliability (consistent results across raters and time) and responsiveness (ability to detect changes in pain, particularly improvement with analgesia) to avoid signal attenuation and ensure true analgesic effects can be identified.
• Blinding and Rigorous Training Mitigate Bias: Outcome assessors must be masked to treatment allocation whenever feasible. Comprehensive rater training and periodic inter-rater reliability checks are crucial to prevent observer drift and ensure data quality, especially in multi-week studies.
• Pilot Testing Identifies Failure Modes: Conducting pilot studies is essential to assess baseline variability, estimate responsiveness, and identify potential ceiling or floor effects that could compress the measurement range and obscure treatment differences, thereby informing sample size calculations and measure selection.

Pain studies in veterinary medicine depend on outcome measures that are valid, repeatable, and responsive to change. The choice of measure determines whether a trial can detect a true analgesic effect, whether results can be compared across studies, and whether findings translate into clinical practice. This article provides a decision framework for veterinary researchers selecting outcome measures for pain studies across species. It covers the scientific basis of pain measurement, criteria for evaluating candidate measures, species-specific considerations, and common failure modes in study design. The intended reader is a veterinary researcher designing a trial, reviewing a protocol, or interpreting published pain research.

The central question this article addresses is practical: how does a researcher choose the right outcome measure for a given pain model, species, and study objective? The answer depends on understanding what each measure actually captures, how it behaves under repeated testing, and what sources of error threaten its validity. A measure that works well for acute postoperative pain in dogs may fail entirely for chronic osteoarthritis pain in cats or for lameness in production animals. The sections that follow build the conceptual foundation for these decisions, then move to selection criteria and implementation guidance.

At a Glance

The Construct of Pain and Its Measurement

Pain is a multidimensional experience with sensory, affective, and cognitive components. In veterinary patients, the affective component cannot be directly assessed by self-report, so researchers must rely on indirect indicators. This fundamental limitation shapes every measurement decision. A behavioral scale captures what an animal does, a physiological measure captures what its body does, and a functional measure captures what it can do. None of these is pain itself. Each is a proxy, and the validity of the proxy determines the validity of the study.

The distinction between nociception and pain matters at the design stage. Nociception is the neural processing of noxious stimuli, and it can occur without the conscious experience of pain. Many physiological measures, such as heart rate or plasma cortisol, reflect nociceptive processing and stress responses instead of pain perception. Behavioral measures are generally considered closer to the pain experience because they reflect integrated central processing. However, behavior is also influenced by fear, handling, social context, and individual temperament. A researcher must decide which construct the study aims to measure and select instruments that align with that construct.

The human literature illustrates the consequences of choosing outcome measures that do not match the construct of interest. In the Women's Health Initiative Memory Study, the primary outcome was incidence of probable dementia, identified through structured clinical assessment, and the trial was stopped early because of increased health risks in the treatment group. The choice of a robust, clinically meaningful primary outcome allowed the trial to answer its question decisively. Veterinary pain studies face the same requirement: the primary outcome must be clinically meaningful and measured with a validated instrument.

Measurement Domains and Their Properties

Pain outcome measures fall into several domains, each with distinct strengths and limitations. Behavioral observation scales, including composite pain scales and visual analogue scales, are the most common in clinical veterinary research. They require trained observers, standardized scoring protocols, and clear operational definitions for each behavior. Physiological measures such as heart rate, respiratory rate, and stress hormone concentrations are objective but nonspecific. They respond to handling, environmental stress, and disease processes unrelated to pain. Functional measures, including gait analysis, force plate assessment, and activity monitoring, capture the impact of pain on daily function. These are particularly valuable for chronic pain studies where spontaneous behavior may change subtly. Quantitative sensory testing, such as mechanical or thermal threshold testing, measures the response to controlled noxious stimuli and is useful for studying hyperalgesia and allodynia.

Owner-reported outcome measures are essential for chronic pain in companion animals because owners observe behavior over long periods in the home environment. These instruments require careful validation of their psychometric properties, including internal consistency, test-retest reliability, and responsiveness to change. The validation burden for owner-reported measures is substantial, and the related article on validating owner-reported outcome measures in veterinary research covers this topic in detail.

The choice of domain should follow the study objective. A trial of perioperative analgesia might prioritize a composite pain scale with demonstrated responsiveness in the immediate postoperative period. A study of osteoarthritis treatment might use a functional outcome such as activity monitoring or owner-reported mobility scores. A mechanistic study of central sensitization might require quantitative sensory testing. No single domain is universally superior, and many high-quality studies include both a primary outcome from one domain and secondary outcomes from others.

Selecting the Outcome Measure Set

The first decision is whether a single measure or a composite set will serve the study objective. A single measure is appropriate when one domain clearly dominates the pain experience for the condition under study, such as lameness score for acute synovitis. A composite set is required when pain has multiple contributors, for example visceral and somatic components after laparotomy, or when the intervention may affect different domains at different rates.

The outcome measure set should be fixed before data collection begins. Changing measures after interim analysis inflates the risk of false-positive findings. The set should include at least one measure from each relevant domain identified in the construct stage, but no more than necessary. Each additional measure increases the burden of data collection, the risk of missing data, and the complexity of multiplicity correction.

Selection criteria for individual measures are:

Species and Setting Constraints

The correct measure depends on the species, the production system, and the patient's ability to perform the behaviors being scored. A scale that requires voluntary locomotion is unusable in a recumbent patient or in a species that is immobilised for safety. A measure that requires facial expression scoring needs a camera and adequate lighting, which may not be available in field conditions.

For production animals, measures must be compatible with handling constraints and must not require restraint that itself alters behavior. Remote observation, such as from a hide or via video, is often necessary. For companion animals, owner-reported measures are feasible but introduce observer variability and the risk of expectation bias. The ARRIVE guidelines for reporting animal research specify that the choice of outcome measures and the methods used to assess them must be reported in sufficient detail to allow replication, including who performed the assessments and how blinding was maintained.

Equipment availability changes the correct choice. Pressure algometry requires a calibrated device and a handler trained in consistent application. Gait analysis requires a walkway and either pressure sensors or motion capture. When such equipment is unavailable, a structured behavioral scale is the pragmatic alternative, but its limitations must be acknowledged in the protocol.

Matching Measures to Pain Type

Acute procedural pain, chronic inflammatory pain, neuropathic pain, and visceral pain each have distinct behavioral signatures. A scale developed for acute postoperative pain may not detect the subtle changes of chronic osteoarthritis. The protocol must specify which pain type is being studied and justify the measures accordingly.

For acute pain, measures of spontaneous behavior, response to palpation, and interaction with the environment are often sufficient. For chronic pain, measures of activity over time, such as accelerometry, and owner-reported quality of life may be more responsive than a single examination score. For neuropathic pain, evoked responses such as allodynia and hyperalgesia require quantitative sensory testing, which is technically demanding and species-specific.

The distinction between pain and other states is critical. Sedation, dysphoria, and fear can mimic or mask pain behavior. A measure that cannot separate these states will produce misleading results. The MSD Veterinary Manual provides species-specific guidance on recognizing pain and distinguishing it from other causes of behavioral change, which should inform the selection of behaviors to be scored.

Psychometric Properties of Commonly Used Scales

The table below lists commonly used pain scales and their documented psychometric properties. The absence of a property in the table means it has not been adequately reported, not that the scale lacks it.

A scale with documented inter-rater reliability in the target species and setting is preferable to one that is merely convenient. The EQUATOR Network reporting guidelines include resources for assessing the reporting quality of studies that develop or validate measurement instruments, which can guide the appraisal of available scales.

Blinding and Rater Training

Blinding is the single most important protection against bias in pain studies. The assessor must be unaware of treatment allocation. When the intervention has visible effects, such as sedation or local swelling, a blinded assessor may be impossible to maintain. In that case, an independent assessor who is not involved in drug administration and who scores from video recordings is the preferred alternative.

Rater training must be documented. Each rater should score a standard set of video recordings before the study begins, and agreement should be calculated. Raters who cannot achieve acceptable agreement should be retrained or excluded. During the study, periodic re-assessment of inter-rater reliability is recommended to detect drift.

The protocol must state who performs the assessments, where they are performed, and under what conditions. A quiet room with consistent lighting and minimal distraction is required for behavioral scoring. The order of assessments should be standardized, and the time of day should be consistent because pain behavior shows circadian variation in some species.

Documentation and Data Quality

Each outcome measure requires a standard operating procedure that specifies the equipment, the positioning of the animal, the sequence of observations, and the recording form. The form should include fields for the date, time, rater identity, animal identification, and any events that could affect the measurement, such as recent handling or medication.

Missing data are inevitable in pain studies. The protocol must define how missing data will be handled in the analysis, whether by complete-case analysis, imputation, or a mixed-effects model that accommodates missing observations. The choice should be made before data collection and justified in the protocol.

The WOAH terrestrial animal health standards address welfare assessment in the context of animal health surveillance, and the principles of standardized observation and documentation apply equally to pain research. Recording the raw data, also the derived scores, allows re-analysis if the scoring system needs revision.

Recognized Complications and Failure Modes

Pain outcome measures fail in characteriztic patterns. The most common failure is signal attenuation, where the chosen instrument cannot detect a true analgesic effect because the pain model produces minimal or highly variable scores. This is detected early by examining baseline score distributions during pilot work. If more than 30% of animals score at the floor or ceiling of the scale, the measure lacks dynamic range for that model. A second failure mode is rater drift, where observers gradually alter their scoring criteria over the course of a multi-week study. Scheduled inter-rater reliability checks every fifth to tenth assessment, with immediate retraining when kappa values fall below 0.6, contain this problem.

A third complication is context sensitivity, where the measure behaves differently across settings. A scale validated in a quiet hospital ward may lose discriminative capacity in a busy emergency room or during farm visits. The ARRIVE guidelines for reporting animal research require explicit description of the assessment environment precisely because context effects are common and poorly predicted. A fourth failure is missing data from animal withdrawal, euthanasia, or owner non-compliance. When missingness exceeds 10% and is associated with treatment group, the trial's conclusions become unreliable regardless of the statistical method applied.

Common Errors and Corrective Actions

Less experienced investigators frequently select a single outcome measure on the assumption that one instrument captures the full pain experience. The corrective action is to recognize that pain is multidimensional and that a single scale measures only the domain it was designed to assess. A second recurring error is the use of a scale in a species or age group for which it was not validated. A feline facial expression scale developed for adult cats should not be applied to kittens without confirmation of its psychometric properties in that population. The MSD Veterinary Manual provides species-specific guidance on pain recognition that can help identify when a scale's assumptions may not hold.

A third error is the failure to randomise assessment order across observers. When one observer assesses all animals in a single treatment group, observer bias becomes confounded with treatment. The corrective action is to assign observers to animals using a schedule that balances treatment groups across raters and time of day. A fourth error is the collection of outcome data by the clinician responsible for animal welfare decisions. This creates an unavoidable conflict between the need to treat and the need to measure. Where possible, a blinded assessor should collect study outcomes while a separate clinician manages analgesia and rescue protocols.

Students and trainees often confuse the intensity of the stimulus with the severity of the pain experience. A surgical incision of fixed length produces variable pain scores across individuals, and the measure must capture the animal's response, not the procedure's magnitude. The corrective action is to train observers to score behavior, not to infer pain from the procedure performed.

Limitations of the Current Evidence

The evidence base for veterinary pain outcome measures remains uneven. Validation studies are published for a limited number of species, primarily dogs, cats, and horses, with far less work in cattle, sheep, pigs, and exotic species. Extrapolation across species is common but frequently unsupported. The EQUATOR Network reporting guidelines include the REFLECT statement for livestock trials, which highlights that reporting quality in production animal research has historically been poor, and this limits the interpretability of many published studies.

Expert opinion still differs on several substantive questions. Whether owner-reported outcomes should be treated as primary or secondary endpoints remains contested, particularly for chronic pain where owner observation is the only practical source of data. Some authorities argue that owner reports are essential and valid, while others maintain that they are too susceptible to placebo effects and wishful thinking. A second area of disagreement concerns the use of composite versus single-domain measures. Composite scales may capture more of the pain experience but are harder to validate and more sensitive to rater error. The Acute Dialysis Quality Initiative consensus process demonstrated in a different field that consensus definitions and standardized endpoints can be achieved through structured review, and a similar approach for veterinary pain outcomes would reduce current heterogeneity.

Referral, Consultation, and Reporting

Specialist consultation is warranted when a study population includes animals with concurrent disease that may confound pain assessment. An animal with osteoarthritis and a separate surgical condition presents measurement challenges that generalizt experience may not resolve. Veterinary anesthesiologists and clinical pharmacologists can advise on outcome selection and on the interpretation of rescue analgesia data.

Laboratory involvement is required when outcome measures include biomarkers, quantitative sensory testing, or gait analysis. These modalities require specialised equipment and quality control procedures that are not available in most practice settings. Regulatory reporting obligations arise when a study reveals unexpected adverse effects associated with an intervention. The AVMA practice resources describe the professional obligations for adverse event reporting, and investigators should familiarise themselves with the requirements of their jurisdiction before commencing a trial. For studies involving food-producing animals, WOAH terrestrial animal health standards may apply where pain outcomes intersect with trade-related animal welfare requirements.

Frequently Asked Questions

How Do I Choose Outcome Measures When Funding or Equipment Is Limited?

Prioritize measures by their contribution to the primary research question, not by convenience. A validated behavioral pain scale administered by a trained, blinded observer outperforms an unvalidated pressure algometer in most clinical settings. If quantitative sensory testing equipment is unavailable, use mechanical or thermal threshold devices only after confirming inter-observer reliability in your hands. Owner-completed questionnaires are inexpensive but require validation in the target language and population before use. The ARRIVE guidelines specify that methods must be described in sufficient detail for replication, which includes naming the exact instrument version and scoring protocol. When resources constrain the measurement set, document the limitation explicitly in the protocol and report it in the final manuscript.

What Should I Do When a Validated Scale Does Not Exist for My Target Species?

Construct a measurement strategy from component parts instead of abandoning quantitative assessment. Use a species-appropriate composite pain scale if one exists for a closely related species, but perform a content validity exercise with three or more experienced clinicians to confirm item relevance. Supplement with physiological variables such as heart rate, respiratory rate, and catecholamine markers, recognizing that these are indirect and influenced by handling stress. Videorecord assessments to permit retrospective scoring by multiple raters. The EQUATOR Network hosts reporting guidelines that help structure the validation process transparently. State clearly in the protocol that the measure is adapted and unvalidated, and plan a pilot study to estimate reliability before the main trial begins.

How Do I Handle Disagreement Between Two Outcome Measures in the Same Study?

Predefine the hierarchy of measures in the statistical analysis plan before data collection starts. If the primary outcome is a behavioral scale and the secondary outcome is a quantitative sensory threshold, a discrepancy should not trigger post hoc reclassification. Analyze both endpoints independently and report effect sizes with confidence intervals for each. Where measures diverge, examine whether the discrepancy clusters by rater, time point, or treatment group. Disagreement between subjective and objective measures may reflect genuine differences in what each instrument detects, not measurement error. The MSD Veterinary Manual notes that clinical signs vary substantially across individuals and conditions, which supports interpreting discordant results as informative instead of invalid.

What Records Must I Keep for Pain Outcome Data to Support Regulatory or Publication Scrutiny?

Maintain a complete audit trail from raw data to final analysis. Store original score sheets, video recordings, calibration logs for any equipment, and rater training certificates. Record the date and time of each assessment, the identity of the assessor, and any deviations from the protocol. Document blinding procedures, including when and how allocation concealment was broken. The ARRIVE guidelines require specification of the experimental unit, blinding, and sample size calculations, and these elements must be traceable in your records. Keep a versioned copy of the scoring manual used during the study. Retain data in a format that allows independent reanalysis, and preserve records for the period required by your institution or funder.

How Should I Explain Outcome Measure Selection to an Owner or Referring Veterinarian?

Frame the explanation around what the measures can and cannot detect. Explain that pain is subjective and that the study uses standardized tools to capture behavior and physical responses consistently across animals. Describe the specific scale or device in plain terms, for example a gait analysis mat measures weight distribution between limbs. Clarify that some measures require the animal to be videorecorded or handled briefly, and state the expected duration. The AVMA practice resources emphasize transparent communication about procedures and their rationale. Offer the owner a written summary of the assessment schedule and reassure them that they can withdraw the animal at any point without affecting routine care.

Does the Choice of Outcome Measure Differ Between Client-Owned Pets and Research Colony Animals?

Yes, and the differences are substantial. Client-owned animals are assessed in variable environments with owner presence, which affects behavior and requires measures robust to contextual noise. Research colony animals can be assessed under controlled conditions, allowing more sensitive instrumentation and repeated baseline measurements. However, colony animals may show habituation to handlers and housing-related stress that confounds pain behavior. Owner-reported measures are feasible in client-owned populations but require validation for proxy reporting. The WOAH terrestrial animal health standards address welfare assessment in production and research settings, and these standards may apply depending on the study context. Match the measurement strategy to the population's environmental reality instead of assuming one protocol transfers across settings.

Related Clinical & Scientific Guides

• Conducting Systematic Reviews of Veterinary Diagnostic Test Accuracy
• Bias in Veterinary Research: Types, Sources, and Mitigation
• Cluster Randomized Trials in Veterinary Research: Design and Analysis

References and Further Reading

• Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group.. 2004.
• The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012.. 2014.
• Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.. 2003.
• Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial.. 2010.
• Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.. 1998.
• Immunosuppression in patients who die of sepsis and multiple organ failure.. 2011.
• ARRIVE Guidelines 2.0 for Reporting Animal Research. PLOS Biology, 2020.
• EQUATOR Network Reporting Guidelines. EQUATOR Network.
• MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.

Related Articles

• Outcome Measures in Veterinary Clinical Trials: Selection and Validation
• Validating Owner-Reported Outcome Measures in Veterinary Research
• Conducting Pharmacovigilance Studies in Veterinary Medicine
• How to Write a Research Protocol for Veterinary Studies
• Designing Dose-Response Studies in Veterinary Pharmacology

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.